Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wenjing Ni
Observed name:
W J Ni
Institutions:
Nanjing University of Chinese Medicine,
Nanjing Drum Tower Hospital,
Nanjing University
Observed institutions:
Nanjing University of Chinese Medicine,
Jiangsu Provincial Academy of Traditional Chinese Medicine,
Nanjing Drum Tower Hospital,
Nanjing University
ORCID:
0000-0001-5241-2304
Observed ORCID:
0000-0001-5241-2304
OpenAlex ID:
A5022996430
Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study
2024
·
Fajuan Rui
, Yee Hui Yeo
, et al.
·
EClinicalMedicine
·
58
PDF
Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study
2025
·
Yu Song
, Wenjing Ni
, et al.
·
Cell Reports Medicine
·
45
Machine Learning–Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic Steatosis
2024
·
Fajuan Rui
, Liang Xu
, et al.
·
Clinical Gastroenterology and Hepatology
·
37
Anthropometric Measures and Mortality Risk in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ): A Population‐Based Cohort Study
2025
·
Yee Hui Yeo
, Yixuan Zhu
, et al.
·
Alimentary Pharmacology & Therapeutics
·
33
PDF
LiverRisk score: An accurate, cost-effective tool to predict fibrosis, liver-related, and diabetes-related mortality in the general population
2024
·
Shanghao Liu
, Xiaohan Chen
, et al.
·
Med
·
24
PDF
Age-specific serum thyrotropin reference range for the diagnosis of subclinical hypothyroidism and its association with lipid profiles in the elderly population
2022
·
Wenjing Ni
, Mengjie Zhang
, et al.
·
Scientific Reports
·
24
PDF
Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD)
2025
·
Qianqian Chen
, Yixuan Zhu
, et al.
·
Communications Medicine
·
23
PDF
Application of machine learning and deep learning in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
2025
·
Huan Zhang
, Xiangyu Wu
, et al.
·
Journal of Advanced Research
·
23
Alcohol Intake Thresholds Among Individuals With Steatotic Liver Disease
2023
·
Yee Hui Yeo
, Yixuan Zhu
, et al.
·
JAMA Network Open
·
17
PDF
Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis
2025
·
Jie Li
, Liang Xu
, et al.
·
Hepatology
·
15
Age-specific association between thyroid autoimmunity and hypothyroidism in Chinese adults aged over 65 years: a cross-sectional study
2023
·
Mengjie Zhang
, Wenjing Ni
, et al.
·
Frontiers in Endocrinology
·
15
PDF
Bone Turnover Markers in Response to Ultrasound-Guided Microwave Ablation for Primary Hyperparathyroidism
2021
·
Wenjing Ni
, Yue Yuan
, et al.
·
Frontiers in Endocrinology
·
13
PDF
Antiviral therapy response in patients with chronic hepatitis B and fatty liver: A systematic review and meta‐analysis
2024
·
Fajuan Rui
, Elizabeth Garcia
, et al.
·
Journal of Viral Hepatitis
·
12
Different minimal alcohol consumption in male and female individuals with metabolic dysfunction‐associated fatty liver disease
2024
·
Yixuan Zhu
, Xiaoming Xu
, et al.
·
Liver International
·
11
PDF
The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes
2024
·
Xiaoyan Ma
, Yixuan Zhu
, et al.
·
Hepatology International
·
11
PDF
Global health burden of cirrhosis and other chronic liver diseases (CLDs) due to non-alcoholic fatty liver disease (NAFLD): A systematic analysis for the global burden of disease study 2019
2023
·
Jie Li
, Qingzhi Wang
, et al.
·
Global Transitions
·
10
Review Article: Impact of Alcohol Consumption on the Development and Progression of Metabolic Dysfunction–Associated Steatotic Liver Disease
2025
·
Yunxuan Lei
, Yixuan Zhu
, et al.
·
Alimentary Pharmacology & Therapeutics
·
7
DiabetesLiver score: A non-invasive algorithm for advanced liver fibrosis and liver-related outcomes in type 2 diabetes mellitus population
2025
·
Chuan Liu
, Jie Shen
, et al.
·
Med
·
7
Dual roles of T cells in metabolic dysfunction–associated steatohepatitis pathogenesis and liver fibrosis: From inflammation to therapeutic targets
2025
·
Yijie Chen
, Bei Jia
, et al.
·
Hepatology Communications
·
6
B cells in metabolic dysfunction-associated steatotic liver disease (MASLD): From mechanisms to therapeutic exploration
2025
·
Leyao Jia
, Xue Bai
, et al.
·
International Immunopharmacology
·
5
The Reduced Accuracy of Non-invasive Tests for Significant Fibrosis in Chronic Hepatitis B Patients with Metabolic Dysfunction-associated Steatotic Liver Disease
2024
·
Fajuan Rui
, Wenjing Ni
, et al.
·
Journal of Clinical and Translational Hepatology
·
5
Laboratory detection of SARS-CoV-2: A review of the current literature and future perspectives
2022
·
Kang-Sheng Liu
, Xiao-Dong Mao
, et al.
·
Heliyon
·
5
Guidelines for Diagnosis and Management of Metabolic Dysfunction-associated Fatty Liver Disease in Primary Care (2025)
2026
·
Wenjing Ni
, Junping Shi
, et al.
·
Journal of Clinical and Translational Hepatology
·
4
PDF
Long-Term Effectiveness of Tenofovir Alafenamide Versus Entecavir in Treatment-Naive Chronic Hepatitis B: A Real-World Evidence from the Global Alliance for the Study of Hepatitis B Virus
2025
·
Jie Li
, Joanne Kimiko Liu
, et al.
·
The American Journal of Gastroenterology
·
4
Superior diagnostic efficacy of Agile 3+ score for diagnosing advanced fibrosis in patients with chronic hepatitis B and concurrent metabolic dysfunction-associated steatotic liver disease
2024
·
Fajuan Rui
, Wenjing Ni
, et al.
·
Journal of Hepatology
·
4
PDF
Show more works
View as search
Works count:
55
Citation count:
448
H-index:
12
I10-index:
16
Year
Topic
Type